Basic Research in the Bladder and Lower Urinary Tract (R01) | Apply Online

Opportunity Summary:

The NIH funding opportunity "Basic Research in the Bladder and Lower Urinary Tract (R01)" (PA-07-023) supports investigator-initiated basic science projects that aim to explain how the bladder and lower urinary tract work in both healthy and diseased states. The emphasis is on fundamental mechanisms at the cellular, molecular, genetic, and developmental levels, rather than clinical trials or purely translational demonstrations. It is sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Cancer Institute (NCI), and the National Institute on Aging (NIA), working in cooperation with the NIH Office of Research on Womens Health (ORWH). A core motivation behind the announcement is to bring new expertise into lower urinary tract research by encouraging investigators from diverse basic science backgrounds to apply their methods and ideas to bladder and lower urinary tract biology, while also strengthening clinician-basic scientist collaborations.

Scientifically, the FOA is broad and welcomes a wide range of foundational topics as long as they meaningfully advance understanding of lower urinary tract structure and function. Priority areas specifically called out include basic cell biology of bladder epithelial cells, smooth muscle cells, and relevant connective tissues, along with studies of organ innervation and vascularization. It also highlights immunobiology and physiology of the bladder and lower urinary tract, recognizing that immune signaling, inflammatory pathways, and host defense can be central drivers of dysfunction. Genomics and proteomics approaches are encouraged, particularly when used to clarify mechanisms and when they address age-related shifts in gene or protein expression that may contribute to functional decline, susceptibility to disease, or altered responses to injury.

The announcement also encourages development and refinement of animal models that better represent normal biology and disease processes of the bladder and lower urinary tract. In infectious disease contexts, it specifically points to pathogen-host interaction studies relevant to bladder infections, which can include mechanistic work on microbial virulence, urothelial defense, immune responses, and factors that influence persistence or recurrence. Another major theme is developmental biology, including investigations into how the lower urinary tract forms and matures, how sex differences shape development and later function, and how aging alters biology in ways that affect continence, storage, voiding, tissue remodeling, or repair capacity. The FOA explicitly signals interest in sex and gender related biology, including basic studies aimed at understanding why women may be predisposed to certain bladder and lower urinary tract disorders, aligning with ORWH priorities.

Because NCI participates, the opportunity also includes strong interest in bladder cancer related fundamental biology, particularly studies focused on the bladder microenvironment (stroma) and how it contributes to carcinogenesis and tumor progression. That framing encourages mechanistic work on stromal-epithelial interactions, extracellular matrix and remodeling, vascular and immune components of the tumor niche, and signaling pathways that shape tumor initiation or invasive behavior. Projects do not need to be cancer-focused to be responsive, but the inclusion of microenvironment biology signals that rigorous basic work connected to bladder carcinogenesis fits squarely within the intended scope.

Methodologically, the FOA encourages innovation in tools and technologies that can move the field forward. This includes the development and application of new methods for in vivo functional assessment, imaging, or other measurement approaches that allow bladder or lower urinary tract function and biology to be quantified more precisely over time or under physiologic conditions. In practical terms, responsive applications could include new imaging techniques, biosensors, functional readouts, or other enabling technologies that unlock experiments previously difficult to perform in living systems, provided the work remains grounded in basic mechanistic questions.

In terms of funding mechanism, this is an NIH R01 opportunity, meaning it is designed for full-scale research projects with a defined set of aims and a robust plan for producing substantial advances in knowledge. It runs in parallel with a companion announcement of identical scientific scope that uses the R21 mechanism (PA-06-255), which is typically used for earlier-stage, exploratory, or high-risk ideas. Applicants whose projects are mature and well-developed would generally align with the R01 track, while more preliminary concepts might be better positioned for the R21 track.

The opportunity is categorized as discretionary grant funding within the health and education activity area, and it lists CFDA numbers tied to cancer biology research (93.396) and aging research (93.866), reflecting the multi-institute nature of the program. There is no cost sharing or matching requirement. The FOA used multiple receipt dates (rather than a single deadline), with details provided in the full announcement. Although the record indicates the FOA was posted in November 2006 and later archived in April 2009, the summary themes remain a useful guide to the kinds of basic bladder and lower urinary tract science NIH institutes were seeking to stimulate through this initiative.

Eligibility is broad and includes a wide spectrum of applicant organizations. Eligible applicants include public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), small businesses and other for-profit organizations, state and local governments (including counties, cities, townships, special districts, and independent school districts), Native American tribal governments and tribal organizations, and public housing authorities/Indian housing authorities. The announcement also states that foreign institutions are eligible to apply, that eligible federal agencies may apply, and that faith-based or community-based organizations can apply, provided they meet NIH requirements for the applicant type and project administration.

Overall, PA-07-023 is best read as a concerted NIH effort to deepen the foundational science of bladder and lower urinary tract biology by supporting mechanistic studies, encouraging new cross-disciplinary participation, promoting clinician-basic scientist partnerships, and advancing enabling technologies. The end goal is to build the basic knowledge needed to improve prevention, diagnosis, and treatment of bladder and lower urinary tract disorders, including conditions influenced by infection, development, aging, sex differences, and cancer-related microenvironmental biology.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Ancillary Studies to Major Ongoing NIDDK and NHLBI Clinical Research Studies (R01)

Previous opportunity: Understanding and Promoting Health Literacy (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 07 023

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 07 023) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 023", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.